US Stock MarketDetailed Quotes

ELEV Elevation Oncology

Watchlist
  • 0.672
  • +0.013+1.93%
Close Feb 14 16:00 ET
  • 0.678
  • +0.006+0.89%
Post 20:01 ET
39.71MMarket Cap-0.84P/E (TTM)

About Elevation Oncology Company

Elevation Oncology, Inc. is a precision oncology company, which engages in the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. The firm’s program is focused on patients with advanced solid tumors harboring an NRG1 fusion. The company was founded by Shawn M. Leland in 2019 and is headquartered in Boston, MA.

Company Profile

SymbolELEV
Company NameElevation Oncology
Listing DateJun 25, 2021
Issue Price16.00
Founded2019
CEOMr. Joseph J. Ferra, Jr
MarketNASDAQ
Employees29
Fiscal Year Ends12-31
Address101 Federal Street,Suite 1900,12th Floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02110
Phone1-716-371-1125
Websitehttp://www.elevationoncology.com

Company Executives

  • Name
  • Position
  • Salary
  • Joseph J. Ferra, Jr
  • President, Chief Executive Officer and Director
  • 1.24M
  • Tammy Furlong
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Valerie Malyvanh Jansen
  • Chief Medical Officer
  • 836.06K
  • Steven A. Elms
  • Chairman of the Board
  • 113.08K
  • Julie M. Cherrington, PhD
  • Independent Director
  • --
  • Dr. Darcy Mootz, PhD
  • Independent Director
  • --
  • R. Michael Carruthers
  • Independent Director
  • 86.48K
  • Dr. Timothy P. Clackson,PhD
  • Independent Director
  • 84.48K
  • Dr. Alan B. Sandler, M.D.
  • Independent Director
  • --

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
HENDERA
831152
+30.00%
Hengerda New Materials
300946
+20.01%
Fujian Nebula Electronics.,Ltd
300648
+20.00%
4
Cubic Digital Technology
300344
+19.98%
5
HNAC Technology
300490
+19.95%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025